This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
這位NANO核能分析師開始看好報道；以下是週三的前5家啓動
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- HC Wainwright & Co. analyst Sameer Joshi initiated coverage on NANO Nuclear Energy Inc. (NASDAQ:NNE) with a Buy rating and announced a price target of $50. Nano Nuclear Energy shares closed at $20.90 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Matthew Caufield initiated coverage on FibroBiologics, Inc. (NASDAQ:FBLG) with a Buy rating and announced a price target of $12. FibroBiologics shares closed at $2.75 on Tuesday. See how other analysts view this stock.
- EF Hutton analyst Jason Kolbert initiated coverage on Invivyd, Inc. (NASDAQ:IVVD) with a Buy rating and announced a price target of $9. Invivyd shares closed at $0.9069 on Tuesday. See how other analysts view this stock.
- EF Hutton analyst Jason Kolbert initiated coverage on Carisma Therapeutics, Inc. (NASDAQ:CARM) with a Buy rating and announced a price target of $24. CARISMA Therapeutics shares closed at $1.01 on Tuesday. See how other analysts view this stock.
- HC韋恩賴特證券公司分析師Sameer Joshi爲NANO核能公司（納斯達克股票代碼：NNE）開始評級，評定爲買入，目標價50美元。Nano核能股票週二收盤價爲20.90美元。看看其他分析師如何看待這支股票。
- HC韋恩賴特證券公司分析師Matthew Caufield爲FibroBiologics公司（納斯達克股票代碼：FBLG）開始評級，評定爲買入，目標價12美元。FibroBiologics股票週二收盤價爲2.75美元。看看其他分析師如何看待這支股票。
- EF赫頓分析師Jason Kolbert爲Invivyd公司（納斯達克股票代碼：IVVD）開始評級，評定爲買入，目標價9美元。Invivyd股票週二收盤價爲0.9069美元。看看其他分析師如何看待這支股票。
- EF赫頓分析師Jason Kolbert爲Carisma Therapeutics公司（納斯達克股票代碼：CARM）開始評級，評定爲買入，目標價24美元。CARISMA Therapeutics股票週二收盤價爲1.01美元。看看其他分析師如何看待這支股票。
Read More:
閱讀更多：
- Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio For October
- 十月份可能拯救您投資組合的前三家科技和電信股票
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。